DrugPatentWatch Database Preview
Details for Patent: 10,232,152
» See Plans and Pricing
Which drugs does patent 10,232,152 protect, and when does it expire?
Patent 10,232,152 protects SINUVA and is included in one NDA.
This patent has eleven patent family members in seven countries.
Summary for Patent: 10,232,152
| Title: | Systems, devices, and method for treating a sinus condition |
| Abstract: | Described here are systems, devices, and methods for delivery of an implant to a bodily cavity. The implant may include a hub and a plurality of legs, and may be moveable between a low-profile and expanded configuration. The systems may include a crimping device having a crimping member with a plurality of arms. The plurality of arms may engage the plurality of legs of the implant, and may move the legs to move the implant to the low-profile configuration. In some instances a delivery device may aid in crimping and/or delivery of the implant. |
| Inventor(s): | Abbate; Anthony J. (Santa Clara, CA) |
| Assignee: | Intersect ENT, Inc. (Menlo Park, CA) |
| Application Number: | 15/007,848 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; Device; |
Drugs Protected by US Patent 10,232,152
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intersect Ent Inc | SINUVA | mometasone furoate | IMPLANT;IMPLANTATION | 209310-001 | Dec 8, 2017 | RX | Yes | No | Start Trial | Start Trial | Y | TREATMENT OF NASAL POLYPS IN PATIENTS >=18 YEARS OF AGE WHO HAVE HAD ETHMOID SINUS SURGERY USING A CORTICOSTEROID-ELUTING (MOMETASONE FUROATE) IMPLANT | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,232,152
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014236729 | Start Trial | |||
| Australia | 2019201045 | Start Trial | |||
| Canada | 2903848 | Start Trial | |||
| China | 105188831 | Start Trial | |||
| European Patent Office | 2968877 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
